Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples